NCT05918068View on ClinicalTrials.gov

Pyridoxine Effect on the Blood Glucose Level in Type 2 Diabetic Patients

NACompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

April 1, 2023

Study Completion Date

April 1, 2023

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Metformin 500 mg/day

Metformin 500 mg/day in addition to non-pharmacological therapy

COMBINATION_PRODUCT

Metformin 500 mg/day plus vitamin B6 300 mg/day

Metformin 500 mg/day plus vitamin B6 300 mg/day in addition to non-pharmacological therapy

OTHER

non-pharmacological therapy

non-pharmacological therapy (healthy lifestyle modifications)

Trial Locations (1)

383421

Maysan Centre for Diabetes and Endocrinology, Maysan Governorate

All Listed Sponsors
lead

Al-Rasheed University College

OTHER